leadf
logo-loader
viewAleafia Health Inc.
(
OTCQX:ALEAF
)

Aleafia Health earns Health Canada permits to export medical cannabis oil to Australia

The Toronto-based company plans to begin shipping within the next month

Australia on a map
Aleafia Health is a vertically integrated cannabis health and wellness company with operations in cultivation, health clinics and cannabis education

Aleafia Health Inc (TSE:ALEF) (OTC:ALEAF) has received the necessary permits from Health Canada to begin exporting cannabis products to Australia, the company announced late Tuesday. 

The Toronto-based company plans to begin shipping its branded medical cannabis oils within the next month. The product will be distributed by CannaPacific Pty Limited, a licensed Australian cannabis producer in which Aleafia Health owns a 10% stake.

READ: Aleafia Health acquires fellow medical cannabis company Emblem at a premium

The permit specifically lets the company export its medical cannabis oils, including its drops and sprays. It previously secured the necessary import permits from Australia's Department of Health. 

“The receipt of Health Canada Export Permits enables Aleafia Health to sell high-margin, value-added cannabis products across international borders for the first time, representing a major milestone as we augment our global distribution platform,” Chairman Julian Fantino said. “With among the largest cultivation and extraction footprints in Canada coming online, we will continue to look to new international markets.”

Aleafia Health is a vertically integrated cannabis health and wellness company with operations in cultivation, health clinics and cannabis education. Its shares slipped 2.2% to C$1.33 and nearly 1% to US$1.04 on OTC Markets.

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com

Follow him on Twitter @andrew_kessel

Quick facts: Aleafia Health Inc.

Follow
OTCQX:ALEAF

Price: 0.23772 USD

Market Cap: $78.62 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Delta 9 Cannabis hit top 10 of Globe and Mail's Top Growth companies survey

Delta 9 Cannabis CEO John Arbuthnot joined Steve Darling from Proactive to share news the company finished 7th in the Globe and Mail’s 3rd Annual Top Company growth survey with 448 entrants based on 3-year growth. Delta 9 saw an increase of revenue over 3 years of 5,413 percent. Arbuthnot...

1 hour, 54 minutes ago

2 min read